Latest Insider Transactions at Neuro Pace Inc (NPCE)
This section provides a real-time view of insider transactions for Neuro Pace Inc (NPCE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NeuroPace Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NeuroPace Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2021
|
Greg Shaw Garfield Director |
BUY
Open market or private purchase
|
Direct |
13,235
+25.41%
|
$224,995
$17.0 P/Share
|
|
Apr 21
2021
|
Frank M Fischer |
BUY
Open market or private purchase
|
Direct |
50,000
+34.89%
|
$850,000
$17.0 P/Share
|
|
Apr 21
2021
|
Accelmed Partners Ii L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
588,235
+50.0%
|
$9,999,995
$17.0 P/Share
|
|
Apr 21
2021
|
Irina Ridley Chief Legal Officer/Secretary |
BUY
Open market or private purchase
|
Direct |
2,352
+50.0%
|
$39,984
$17.0 P/Share
|
|
Apr 21
2021
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
235,000
+50.0%
|
$3,995,000
$17.0 P/Share
|